Henry Schein Inc banner

Henry Schein Inc
XMUN:HS2

Watchlist Manager
Henry Schein Inc Logo
Henry Schein Inc
XMUN:HS2
Watchlist
Price: 67.25 EUR 0.75% Market Closed
Market Cap: €8.7B

EV/FCFF

22.8
Current
3%
Cheaper
vs 3-y average of 23.6

Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.

EV/FCFF
22.8
=
Enterprise Value
€11.6B
/
Free Cash Flow to Firm
$521m

Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.

EV/FCFF
22.8
=
Enterprise Value
€11.6B
/
Free Cash Flow to Firm
$521m

Valuation Scenarios

Henry Schein Inc is trading below its 3-year average

If EV/FCFF returns to its 3-Year Average (23.6), the stock would be worth €69.6 (3% upside from current price).

Statistics
Positive Scenarios
3/4
Maximum Downside
-4%
Maximum Upside
+3%
Average Upside
1%
Scenario EV/FCFF Value Implied Price Upside/Downside
Current Multiple 22.8 €67.25
0%
3-Year Average 23.6 €69.6
+3%
5-Year Average 22 €64.66
-4%
Industry Average 23 €67.85
+1%
Country Average 23.2 €68.41
+2%

Forward EV/FCFF
Today’s price vs future free cash flow to firm

Not enough data available to calculate forward EV/FCFF

Peer Comparison

All Multiples
EV/FCFF
P/E
All Countries
Close

Market Distribution

In line with most companies in the United States of America
Percentile
47th
Based on 8 393 companies
47th percentile
21.7
Low
0 — 15.4
Typical Range
15.4 — 35.1
High
35.1 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 15.4
Median 23.2
70th Percentile 35.1
Max 3 178 983.5

Henry Schein Inc
Glance View

In the evolving landscape of healthcare distribution, Henry Schein Inc. has carved out a robust niche, establishing itself as a pivotal player in delivering essential products and services. Founded in 1932, the company initially responded to the growing need for medical supplies with a simple commitment to customer service and innovation. Today, the company profiles as the world’s largest provider of healthcare products and services to office-based dental and medical practitioners, alongside its veterinary arm. It services a global footprint, channeling its efforts into dental, medical, and animal health sectors. The company's sprawling network deploys a vast array of products—from consumables to equipment—to a multitude of healthcare professionals, accentuating its integral role in the clinical toolkit. Henry Schein's revenue engine thrives on a meticulously crafted business model that combines the breadth of a comprehensive catalog with targeted value-added services. Its diverse product offerings span dental implants, vaccines, pharmaceuticals, and surgical supplies, delivered through direct sales and sophisticated logistical frameworks. Moreover, Henry Schein supplements its product lines with a suite of services, including practice management solutions and e-commerce platforms, that streamline operations for practitioners and enhance client loyalty. Strategic partnerships and acquisitions show the company's commitment to innovation, driving efficiencies and expanding its reach. This continuous adaptation keeps Henry Schein at the forefront of healthcare trends, ensuring steady streams of income flowing from both longstanding relationships and new market opportunities.

HS2 Intrinsic Value
90.91 EUR
Undervaluation 26%
Intrinsic Value
Price €67.25
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett